World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
Authors:
- Rajiv TandonRTRajiv Tandon
- R H BelmakerRBR H Belmaker
- Wagner F GattazWGWagner F Gattaz
- Juan J Lopez-IborJLJuan J Lopez-Ibor
- Ahmed OkashaAOAhmed Okasha
- Bruce SinghBSBruce Singh
- Dan J SteinDSDan J Stein
- Jean-Pierre OlieJOJean-Pierre Olie
- W Wolfang FleischhackerWFW Wolfang Fleischhacker
- Hans-Juergen MoellerHMHans-Juergen Moeller
- Section of Pharmacopsychiatry, World Psychiatric AssociationSASection of Pharmacopsychiatry, World Psychiatric Association
- 1 March 2008
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 100 (1-3) , 20-38
Abstract
No abstract availableKeywords
This publication has 121 references indexed in Scilit:
- The case for long‐acting antipsychotic agents in the post‐CATIE eraActa Psychiatrica Scandinavica, 2007
- EPS Profiles: The Atypical AntipsychoticsJournal of Psychiatric Practice, 2007
- Consumer Perspectives on Quality of Care in the Treatment of SchizophreniaAdministration and Policy in Mental Health and Mental Health Services Research, 2006
- Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up studyBMJ, 2006
- Sharing decisions in consultations involving anti-psychotic medication: A qualitative study of psychiatrists’ experiencesSocial Science & Medicine, 2006
- Pharmacoeconomic modelling in schizophreniaThe European Journal of Health Economics, 2006
- Treatment of Schizophrenia Negative Symptoms: Future ProspectsSchizophrenia Bulletin, 2006
- External validity of randomised controlled trials: “To whom do the results of this trial apply?”The Lancet, 2005
- Comparing efficacy of first-line atypical antipsychotics: no evidence of differential efficacy between risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazoleInternational Journal of Psychiatry in Clinical Practice, 2005
- What's atypical about atypical antipsychotic drugs?Current Opinion in Pharmacology, 2004